BIOFRONTERA INC.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$29M
↑+29.2% +$6Mvs FY2024
Total Liabilities
$18M
↑+2.4% +$416Kvs FY2024
Equity
$10M
↑+136.4% +$6Mvs FY2024
Cash
$6M
↑+8.2% +$487Kvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $29M | $22M |
| Current Assets | $18M | $21M |
| Cash | $6M | $6M |
| ST Investments | $0 | $0 |
| Receivables | $7M | $5M |
| Inventory | $1M | $7M |
| Other Current | $3M | $3M |
| Non-Current Assets | $10M | $1M |
| PPE | $2M | $80K |
| Goodwill | $0 | $0 |
| Intangibles | $3M | $35K |
| Investments | $0 | $0 |
| Other Non-Current | $6M | $1M |
| Total Liab+Eq | $29M | $22M |
| Current Liab. | $12M | $12M |
| Accounts Payable | $0 | $0 |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $0 |
| Other CL | $12M | $12M |
| Non-Current Liab. | $6M | $6M |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $6M | $6M |
| Equity | $10M | $4M |
| Retained Earnings | $128M | $117M |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · BFRI · Comparing FY2025 vs FY2024